Individual and simultaneous spectrophotometric determination of dapsone and metoclopramide HCL in pharmaceutical dosage forms and synthetic binary mixtures

Chemical and Pharmaceutical Bulletin

Volumn 53, Issue 11, 2005, Pages 1498-1501

  Omran, Ahmed Ahmed ^a,b  

^a Assiut Branch   (Egypt)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Dapsone; Dosage form; Metoclopramide; Simultaneous determination; Synthetic mixture

Indexed keywords

AZO COMPOUND; AZO DYE; BENZOYLACETONE; DAPSONE; KETONE DERIVATIVE; METOCLOPRAMIDE; UNCLASSIFIED DRUG;

ABSORPTIOMETRY; ALKALINITY; ARTICLE; CROSS COUPLING REACTION; DRUG ABSORPTION; DRUG DETERMINATION; DRUG DOSAGE FORM; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY; VALIDATION PROCESS;

ANTIEMETICS; BUTANONES; DAPSONE; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; LEPROSTATIC AGENTS; METOCLOPRAMIDE; PHARMACEUTICAL SOLUTIONS; REFERENCE STANDARDS; SODIUM NITRITE; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS;

EID: 27744525379     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.53.1498     Document Type: Article

References (25)

1. Shepard C. C., Ann. Rev. Pharmacol., 9, 37-50 (1969).
2. Ponte C. D., Nappi J. M., Am. J. Hosp. Pharm., 38, 829-833 (1981).
3. Kwadijk S., Torano J. S., Biomed. Chromatogr., 16, 203-208 (2002).
4. Moncrieff J., J. Chromatogr. B: Biomed. Appl., 654, 103-110 (1994).
5. Chiba R., Ogasawara A., Kubo T., Yamazaki H., Unimo M., Ishizuka Y., Anal. Sci., 19, 785-789 (2003).
6. Suleiman M. S., Najib N. M., el-Sayed Y. M., Badwan A., Analyst (London), 114, 365-368 (1989).
7. Tam Y. K., Axelson J. E., J. Pharm. Sci., 67, 1073-1077 (1978).
8. Riggs K. W., Axelson J. E., Rurak D. W., Hasman D. A., McErlan B., Bylsma-Howell M., McMorland G. H., Ongley R., Price J. D., J. Chromatogr., 276, 319-328 (1983).
9. Ross-Lee L. M., Eadie M. J., Bochner F., Hooper W. D., Tyrer J. H., J. Chromatogr., 183, 175-184 (1980).
10. Riggs K. W., Szeitz A., Rurak D. W., Mutlib A. E., Abbott F. S., Axelson J. E., J. Chromatogr. B: Biomed. Appl., 660, 315-325 (1994).
11. British Pharmacopoeia, Vol. I, The Stationary Office under License from the Controller of Her Majesty's Stationary Office, London, 1993, pp. 197, 429.
12. The United State Pharmacopoeia, United States Pharmacopieal Convention, 1980, Vol. XX, p. 197
13. The United State Pharmacopoeia, United States Pharmacopieal Convention, Vol. XXI, p. 273.
14. Nagaraja P., Yathirajan H. S., Raju C. R., Vasantha R. A., Nagendra P., Kumar M. S. H., Farmaco, 58, 1295-1300 (2003).
15. Nagaraja P., Yathirajan H. S., Sunitha K. R., Vasantha R. A., Anal. Lett., 35, 1531-1540 (2002).
16. Revanasiddappa H. D., Manju B., Drug Dev. Ind. Pharm., 28, 515-521 (2002).
17. Revanasiddappa H. D., Manju B., J. Pharm. Biomed. Anal., 25, 631-637 (2001).
18. Abdel-Gawad F. M., El-Guindi N. M., Anal. Lett., 28, 1437-1447 (1995).
19. Amin A. S., Ragab G. H., Anal. Sci., 19, 747-751 (2003).
20. El-Gendy A. E., Spectroscopy Lett., 25, 1297-1313 (1992).
21. Moussa B. A., J. Pharm. Biomed. Anal., 23, 1045-1055 (2000).
22. Shoukrallah I., Sakla A., Wintersteiger R., Pharmazie, 25, 675-677 (1990).
23. Wang H. Y., Xu L. X., Xiao Y., Han J., Spectrochim. Acta A, 60, 2933-2939 (2004).
24. Savitzky A., Golay M. J. E., Anal. Chem., 36, 1627-1639 (1964).
25. Bates R. G., Bower V. E., Anal. Chem., 28, 1322-1324 (1956).